241 related articles for article (PubMed ID: 34762301)
1. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
2. Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China.
Wang Z; Chen R; Zhang L; Chen Y; Li J; Li S; Xu L; Hu Y; Bai Y
Eur J Cancer Prev; 2024 Jul; 33(4):347-354. PubMed ID: 38375832
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study.
Chung KC; Juang SE; Chen HH; Cheng KC; Wu KL; Song LC; Lee KC
BMC Gastroenterol; 2022 Nov; 22(1):453. PubMed ID: 36368935
[TBL] [Abstract][Full Text] [Related]
4. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
5. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
Jin EH; Han K; Lee DH; Shin CM; Lim JH; Choi YJ; Yoon K
Gastroenterology; 2022 Sep; 163(3):637-648.e2. PubMed ID: 35643169
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome, metabolic components, and their relation to the risk of pancreatic cancer.
Park SK; Oh CM; Kim MH; Ha E; Choi YS; Ryoo JH
Cancer; 2020 Jan; 126(9):1979-1986. PubMed ID: 32012239
[TBL] [Abstract][Full Text] [Related]
7. The relationship between metabolic syndrome and the incidence of colorectal cancer.
Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Syndrome Components and the Risk of Colorectal Cancer: A Population-Based Prospective Study in Chinese Men.
Li X; Chen H; Wang G; Feng X; Lyu Z; Wei L; Wen Y; Chen S; Wu S; Hang D; Dai M; Li N; He J
Front Oncol; 2019; 9():1047. PubMed ID: 31681585
[No Abstract] [Full Text] [Related]
10. Association between metabolic syndrome and incidence of cholelithiasis in the Korean population.
Kim Y; Oh CM; Ha E; Park SK; Jung JY; Ryoo JH
J Gastroenterol Hepatol; 2021 Dec; 36(12):3524-3531. PubMed ID: 34097775
[TBL] [Abstract][Full Text] [Related]
11. Plant-based diets and incident metabolic syndrome: Results from a South Korean prospective cohort study.
Kim H; Lee K; Rebholz CM; Kim J
PLoS Med; 2020 Nov; 17(11):e1003371. PubMed ID: 33206633
[TBL] [Abstract][Full Text] [Related]
12. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
13. Relation of the Metabolic Syndrome to Incident Colorectal Cancer in Young Adults Aged 20 to 49 Years.
Jimba T; Kaneko H; Yano Y; Itoh H; Yotsumoto H; Seki H; Morita K; Kiriyama H; Kamon T; Fujiu K; Michihata N; Jo T; Takeda N; Morita H; Nishiyama A; Node K; Yasunaga H; Komuro I
Am J Cardiol; 2021 Nov; 158():132-138. PubMed ID: 34481589
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
[TBL] [Abstract][Full Text] [Related]
16. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Ding C; Yang Z; Wang S; Sun F; Zhan S
Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
[TBL] [Abstract][Full Text] [Related]
17. The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer.
Liu T; Fan Y; Zhang Q; Wang Y; Yao N; Song M; Zhang Q; Cao L; Song C; Shi H
Inflamm Res; 2022 Aug; 71(7-8):899-909. PubMed ID: 35715516
[TBL] [Abstract][Full Text] [Related]
18. The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study.
Moon SG; Park B
J Prev Med Public Health; 2022 Sep; 55(5):475-484. PubMed ID: 36229910
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study.
Zhang S; Wang D; Zhao J; Zhao H; Xie P; Zheng L; Sheng P; Yuan J; Xia B; Wei F; Zhang Z
BMC Public Health; 2024 Jan; 24(1):233. PubMed ID: 38243159
[TBL] [Abstract][Full Text] [Related]
20. Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).
Ku MS; Chiu SY; Chien KL; Lee YC; Chen SL; Chen CD
Medicine (Baltimore); 2021 Jun; 100(22):e26121. PubMed ID: 34087861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
